SCHEMBL6977210

SCHEMBL6977210

CCOC(=O)[N+](C)(C(=O)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HDAC1 Q13547 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
ALDH1A1 P00352 6/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
HPGD P15428 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
USP14 P54578 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7401529 0.89 PLG (0.39) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL7948828 0.79 ITK (0.45) TP53MEN1KMT2AHDAC1HDAC8
Hydrochloric Acid SCHEMBL6985560 0.78 F2 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6983536 0.78 TP53 (0.43) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL6985246 0.77 TP53 (0.51) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL6986538 0.76 TP53 (0.49) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL6979174 0.76 TP53 (0.50) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL6981826 0.75 PDK1 (0.52) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL7959057 0.75 PDK1 (0.41) TP53MEN1KMT2AHDAC1HDAC8
SCHEMBL6977731 0.75 TP53 (0.45) TP53MEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed